AI-generated summary
This review discusses laser therapy for genitourinary syndrome of menopause and stress urinary incontinence, including microablative fractional CO2 laser and vaginal Er:YAG laser. The authors report that data from non-randomized clinical trials suggest laser therapy can alleviate vaginal dryness and dyspareunia, and that the evidence suggests vaginal Er:YAG laser may be an alternative to hormone replacement therapy. Large randomized trials have not been reported.
- Who or what was studied
- Women with genitourinary syndrome of menopause or stress urinary incontinence
- Limits stated in the abstract
- Large randomized trials have not been reported, and the authors state that randomized studies are needed to compare treatments and assess duration and repeated-application safety.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.